BTIG Elevates Guardant Health to Its Top Healthcare Pick After Strong Q2 Performance
BTIG has designated Guardant Health as its preferred pick in the healthcare sector, keeping a Buy rating and increasing its price target to $195 after the company posted robust second-quarter results driven by significant oncology volume growth and an upward revision to full-year guidance. BTIG cites the firm's leadership in liquid biopsy diagnosti…